Related Experiment Video
Updated: Jul 16, 2026

From a 2DE-Gel Spot to Protein Function: Lesson Learned From HS1 in Chronic Lymphocytic Leukemia
Published on: October 19, 2014
Plasmacytoid dendritic cell leukaemia/lymphoma: towards a well defined entity?
Francine Garnache-Ottou1, Jean Feuillard, Philippe Saas
1EFS BFC, Haematology and Immunology Laboratory, Besançon, France. francine.garnache@efs.sante.fr
Early plasmacytoid dendritic cell leukaemia/lymphoma (pDCL) is a rare aggressive cancer. Researchers propose new markers like blood dendritic cell antigen-2 and CD123 for improved diagnosis of this CD4(+)/CD56(+) neoplasm.
Area of Science:
- Hematology
- Oncology
- Immunology
Background:
- CD4(+)/CD56(+) haematodermic neoplasm, or early plasmacytoid dendritic cell leukaemia/lymphoma (pDCL), is a recognized entity in cutaneous lymphoma classifications.
- This leukaemia/lymphoma originates from plasmacytoid dendritic cells and characteristically co-expresses CD4 and CD56 markers without other lineage-specific markers.
Purpose of the Study:
- To identify specific validated markers for the diagnosis of aggressive pDCL.
- To propose an improved diagnostic approach for pDCL.
Main Methods:
- Analysis of marker expression patterns in pDCL.
- Evaluation of potential diagnostic markers including T-cell leukaemia 1, blood dendritic cell antigen-2, and CD123.
Main Results:
- Plasmacytoid dendritic cell leukaemia/lymphoma exhibits a generally homogeneous marker profile but with notable variations.
- Blood dendritic cell antigen-2 and high CD123 expression are proposed as potential diagnostic markers for pDCL.
Conclusions:
- Accurate diagnosis of pDCL requires specific validated markers due to its aggressive nature and potential for aberrant marker expression.
- A multidisciplinary approach integrating various hematology fields is recommended to enhance pDCL diagnosis.
More Related Videos
08:01Fluorescence-activated Cell Sorting for Purification of Plasmacytoid Dendritic Cells from the Mouse Bone Marrow
Published on: November 4, 2016
13:34Assessing the Development of Murine Plasmacytoid Dendritic Cells in Peyer's Patches Using Adoptive Transfer of Hematopoietic Progenitors
Published on: March 17, 2014
Related Concept Videos
Disorders of Leukocytes
Leukopenia may result from bone marrow disorders, autoimmune diseases, and infectious diseases. For example, conditions such as multiple myeloma and aplastic anemia can impair the bone marrow's ability to produce adequate leukocytes. Similarly, autoimmune diseases like lupus and viral infections such as HIV can prompt the immune system...
Lymphoid Cells and Tissues
Lymphoid cells consist of various types of immune system cells. These include B and T lymphocytes, which are responsible for producing antibodies and killing infected cells, respectively. Dendritic cells act as messengers between the innate and adaptive...
Primary Lymphoid Organs
The red bone marrow is a soft, spongy tissue nestled in the interior of long bones such as the humerus and femur. It is the site...
Differentiation of Common Myeloid Progenitor Cells